MDS Pharma Services Expands Development & Regulatory Services in Europe

King Of Prussia, Pennsylvania (ots/PRNewswire) - MDS Pharma
Services, a leading provider of innovative drug discovery and
development solutions, announced today the expansion of its
Development & Regulatory Services (DRS) business in Europe. MDS
Pharma Services will now offer full-service DRS consulting services
to support development of new drugs and biopharmaceutical products
for clients in Europe.

The MDS Pharma Services' European DRS organization will also be
fully integrated with consultants in the United States and Canada to
provide product development consulting, program management, and
regulatory affairs services for new drugs and biopharmaceutical
products.

"This expansion in Europe will greatly broaden our consulting
capabilities in development and regulatory services," said MDS Pharma
Services President David Spaight. "We will now be able to provide
expertise to support our biotechnology and Asian pharmaceutical
clients in the process of commercializing their products in North
American and European markets."

This European expansion is being supported by the appointments of
two industry experts, Dr. Didier Saur, MD as Vice-President of
Medical Affairs, and Dr. Sarah Roberts, Ph.D. as Senior Director of
Regulatory Affairs.

Based near Paris in Sèvres, France, Dr. Saur will lead the MDS
Pharma Services product development consulting, program management,
and regulatory affairs services for drugs and biopharmaceutical
products in Europe. He will also be responsible for organizing and
chairing the Medical Advisory Board for DRS. Dr. Saur has more than
20 years experience as a physician in the pharmaceutical and contract
research industry. Trained in internal and intensive care medicine,
clinical pharmacology and statistics, he is a specialist in
cardiovascular and metabolic disorders such as diabetes and obesity.

Based in Winnersh, near London, Dr. Roberts will provide expert
regulatory affairs consulting for clients on European regulatory
issues. An oncology research specialist with more than 10 years
experience, Dr. Roberts has worked with the Dana Farber Cancer
Institute in Boston, Massachusetts and the Gray Cancer Institute in
London, England. She has considerable experience with regulatory
agencies in both North America and Europe, and most recently served
as a Director for Smart Regulatory Solutions Ltd, an independent
consulting firm she established.

About MDS Pharma Services

MDS Pharma Services offers a full spectrum of resources to meet
the drug discovery and development needs of the pharmaceutical and
biotechnology industries. With numerous facilities strategically
located around the world, we apply advanced scientific and
technological expertise throughout the drug discovery and development
process - from lead optimization, pre-IND research, early clinical
research (bioequivalence, phases I-IIa) and bioanalysis through to
global clinical development (phases IIb-IV), central lab and
centralized cardiac services. For more information, visit our website
at www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS;
NYSE: MDZ), a global life sciences company that provides
market-leading products and services our customers need for the
development of drugs and diagnosis and treatment of disease. We are a
leading global provider of pharmaceutical contract research, medical
isotopes for molecular imaging, radiotherapeutics, and analytical
instruments. MDS has more than 6,200 highly skilled people in 28
countries. Find out more at www.mdsinc.com or by calling
1-888-MDS-7222, 24 hours a day.

ots Originaltext: MDS Pharma Services
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information: For Investors, Sharon Mathers,
+1-416-675-6777 ext. 34721, sharon.mathers@mdsinc.com; For Media,
Charlene McGrady, +1-610-239-7900 ext. 231,
charlene.mcgrady@mdsinc.com